- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 238 results
Webinar
февраля 23, 2023
MDLs: Judges, Defendants and Plaintiffs Too – Who Is Buzzing About What?
Webinar
февраля 15, 2023
Healthcare Fraud Enforcement Update - What Does 2023 Hold?
Webinar
января 31, 2023
Best Practices for UK & EU Fund Managers Raising Capital in the GCC
Webinar
января 24, 2023
Year in Review for Drug and Device Advertising and Promotion: Lessons Learned From 2022 FDA Enforcement Letters and Other Key Developments
Webinar
января 19, 2023
A New Year, A New Day - What’s Next for Healthcare Policy and Oversight in the New Congress
Webinar
декабря 8, 2022
Physician Practice Acquisitions Roundtable: Considerations for Negotiating on Behalf of Buyers and Sellers
Webinar
декабря 6, 2022
Structured Finance Opportunities in a Distressed Environment
Webinar
ноября 30, 2022
Are You Prepared? FDA’s Proposed Rules to Modify Protection of Human Subjects and IRB Oversight
Webinar
ноября 17, 2022
State Attorneys General Election Results and What to Expect in 2023
Webinar
ноября 9, 2022
Talk im Turm – German Whistleblower Protection Act and Supply Chain Due Diligence Obligations
Webinar
ноября 7, 2022
9th Annual Cybersecurity & Privacy Summit
Webinar
октября 25, 2022
FDA’s Changing Approach to Regulating Clinical Decision Support Software